KF VENTURES
We invest in founder-led, science-led biotechnology companies
with non-incremental strategies for improving human health.
KF Ventures was founded by science and tech entrepreneurs looking to support like-minded entrepreneurs with ambitious ideas. History tells us that the paradigm shifts don't start from investor put-togethers, corporate insiders, large war chests, or industry celebrity boards, but from scrappy founders. Life sciences companies are no exception.
​
​
​
KF VENTURES
FEATURED INVESTMENTS
Herophilus is a neurotherapeutics discovery company based on next-generation scaled complex in vitro models.
Acquired by Roche, Oct 2023
Onc.AI is a digital health company on a mission to radically improve oncology decision making.
Tegmine combines mass spectrometry, machine learning, and biology to develop highly selective antibody drug targets for oncology.
DotLab is a women’s healthcare technology company developing a circulating micro RNA blood test to diagnose active endometriosis.
Stealth co.
Mol Dyn meets LLMs.